Home Archive
Archive
2026 Volume 47 Issue 7  Published: 2026-07-10
    Topic
  • Bingbing ZHU , Ying FAN , Niansong WANG
    doi: 10.13683/j.wph.2026.07.001

    Nephrotic syndrome(NS) is a group of clinical syndromes characterized by massive proteinuria, hypoproteinemia, edema and hyperlipidemia. At present, its clinical treatment still faces prominent challenges including limited remission rate, high recurrence rate and adverse reaction of long-term medication. In recent years, novel small-molecule inhibitors targeting B cells and inflammatory signaling pathways, such as Bruton's tyrosine kinase inhibitors, spleen tyrosine kinase inhibitors and Janus kinase inhibitors, have become a key research direction in the field of kidney disease treatment, dues to their advantages of high target specificity and convenient administration. This paper systematically reviewed the mechanisms of action, preclinical and clinical research progress of the above three categories of inhibitors, discussed their application value and existing challenges in NS treatment, so as to provide references for clinical practice.

  • Topic
  • Junli GAO , Niansong WANG
    doi: 10.13683/j.wph.2026.07.002

    Steroid-resistant nephrotic syndrome(SRNS) in children is one of the most challenging disease entities in the field of pediatric nephrology, with a high long-term risk of progressing to end-stage renal disease. Calcineurin inhibitors, mainly including tacrolimus and cyclosporine A, are currently the first-line immunosuppressive agents for the treatment of non-genetic(idiopathic) childhood SRNS. This paper systematically reviewed the efficacy differences of calcineurin inhibitors in different types of childhood SRNS, as well as their core role in combination and sequential therapy. It also discussed the application status of these agents in economically underdeveloped areas and the future research directions, to provide references for further optimizing the individualized treatment strategies for childhood SRNS.

  • Article
  • Yuling ZHENG , Yan LIANG , Li XU , Shang ZHANG , Yingyuan XIAO , Guobin ZHANG
    doi: 10.13683/j.wph.2026.07.003
    Objective

    To explore the chondroprotective effect of chlorogenic acid on rats with knee osteoarthritis(KOA) and its underlying mechanism.

    Methods

    A KOA rat model was established and randomly divided into the blank group, the model group, the high-dose chlorogenic acid group(20 mg/kg), the low-dose chlorogenic acid group(10 mg/kg), and the positive control group(dipivefrin 50 mg/kg). The knee joint functions and the severity of cartilage lesions among different groups, the levels of serum tumor necrosis factor(TNF)-α, interleukin(IL)-1β, the levels of matrix metalloproteinase (MMP)-13 in synovial fluid, disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS)-5 in synovial fluid, and the gene and protein expressions of factors related to the cartilage Toll-like receptor(TLR) 4/nuclear factor(NF)-κB signaling pathway were compared.

    Results

    Compared with the model group, the chlorogenic acid group showed a significantly reduced Lequesne MG score for knee joint function(P<0.05), significantly lower Mankin's score for joint cartilage lesions(P<0.01), significantly decreased serum TNF-α and IL-1β and the levels of MMP-13 and ADAMTS-5 in synovial fluid (P<0.01), and significantly downregulated the gene expressions of TLR4, MyD88, and NF-κB p65 in knee joint cartilage and the relative expressions of TLR4/β-actin, MyD88/β-actin, and p-NF-κB p65/NF-κB p65 proteins(P<0.01). The improvement in the high-dose chlorogenic acid group was better than that in the low-dose chlorogenic acid group, and there was a dose-dependent trend.

    Conclusion

    Chlorogenic acid can effectively improve the knee joint function and protect the articular cartilage of KOA rats, which may be related to its inhibition of the TLR4/NF-κB signaling pathway and thereby downregulating the expression of inflammatory factors and matrix-degrading enzymes.

  • Article
  • Xueqin WANG , Zhengding DENG , Gang XUE
    doi: 10.13683/j.wph.2026.07.004
    Objective

    To observe the efficacy of Mahuang Danggui powder in treating acute exacerbation of cold-type bronchial asthma.

    Methods

    A total of 120 patients with acute exacerbation of cold-type bronchial asthma were randomly divided into the treatment group and the control group, with 60 cases in each group. Both groups received nebulized inhalation therapy with budesonide suspension for inhalation. The treatment group additionally received Mahuang Danggui powder. The acute exacerbation clinical feature scores, forced expiratory volume in one second as a percentage of predicted value(FEV1%pred), peak expiratory flow(PEF), eosinophil(EOS) count, levels of total immunoglobulin E(IgE), interleukin(IL)-4, and IL-5 were compared between the two groups before and after treatment.

    Results

    After treatment, the clinical feature scores decreased in both groups, and the scores in the treatment group were significantly lower than those in the control group(P<0.05). After treatment, FEV1%pred and PEF in both groups increased compared with those before treatment, and the values in the treatment group were higher than those in the control group(P<0.05). After treatment, the levels of EOS, total IgE, IL-4, and IL-5 in both groups decreased compared with those before treatment, and the levels in the treatment group were lower than those in the control group(P<0.05). No significant adverse reactions were observed in either group.

    Conclusion

    Mahuang Danggui powder is effective in the treatment of acute exacerbation of cold-type bronchial asthma.

  • Article
  • Minzhe HUANG , Lisheng WANG , Xueqin XIONG , Renli HUANG
    doi: 10.13683/j.wph.2026.07.005
    Objective

    To explore the therapeutic effect of modified Danggui decoction combined with Chaihu Shugan powder as an adjuvant therapy for gastroesophageal reflux disease(GERD) with liver-stomach disharmony syndrome, and its influence on esophageal motility, gastrointestinal hormones, neurotransmitters and T-cell immune function.

    Method

    A total of 136 GERD patients with liver-stomach disharmony syndrome admitted to our hospital from May 2024 to June 2025 were selected and divided into the reference group and the combined group randomly, with 68 cases in each group.The reference group received conventional western medicine treatment, while the combined group was additionally treated with modified Danggui decoction combined with Chaihu Shugan powder, both groups received 4 weeks of treatment. The clinical efficacy, adverse reactions, and the changes of upper esophageal sphincter pressure(UESP), lower esophageal sphincter pressure(LESP), distal contraction integral(DCI), gastrin(GAS), motilin(MTL), vasoactive intestinal peptide(VIP), brain-derived neurotrophic factor(BDNF), 5-hydroxytryptamine(5-HT), γ-aminobutyric acid(GABA), helper T cell(Th)1, Th2, Th1/Th2, Th17/regulatory T cell(Treg) levels before and after treatment were compared between the two groups. The 6-month recurrence rate after treatment was statistically analyzed in both groups.

    Results

    During the study period, 1 case withdrew and 2 cases were lost to follow-up in the reference group, 1 case voluntarily withdrew and 1 case was lost to follow-up in the combined group. Finally, 65 cases in the reference group and 66 cases in the combined group were included for analysis. After treatment, the total effective rate of the combined group was higher than that of the reference group(89.39% vs. 69.23%, P<0.05). The levels of UESP, LESP, DCI, GAS, MTL, BDNF, 5-HT, GABA and Th2 in both groups were improved compared with those before treatment, and the above indicators in the combined group were superior to those in the reference group(all P<0.05). The levels of VIP, Th1, Th1/Th2 and Th17/Treg in both groups were decreased compared with those before treatment, and the above indicators in the combined group were lower than those in the reference group(all P<0.05). The incidence of adverse reaction in the combined group was lower than that in the reference group(6.06% vs. 10.77%), but the difference was not statistically significant(P>0.05).Follow-up after treatment for 6 months, the recurrence rate of the combined group was lower than that of the reference group(9.09% vs. 27.69%, P<0.05).

    Conclusion

    Modified Danggui decoction combined with Chaihu Shugan powder has definite curative effect in adjuvant treatment of GERD with liver-stomach disharmony syndrome. It can improve esophageal motility, bidirectionally regulate gastrointestinal hormones and neurotransmitters, and reconstruct T-cell immune homeostasis, with good safety and low long-term recurrence rate.

  • Article
  • Fei YU , Xue SONG , Wen WANG
    doi: 10.13683/j.wph.2026.07.006
    Objective

    To explore the clinical efficacy of Chanbei mixture in the treatment of post-infectious cough(PIC), and its regulatory effect on serum immunoglobulin(Ig)E, peripheral blood eosinophil(EOS) count, tumor necrosis factor(TNF)-α and interleukin(IL)-6 levels in patients.

    Methods

    A total of 136 PIC patients admitted to our hospital from August 2024 to April 2025 were enrolled as research subjects, and randomly divided into the control group(n=68, conventional treatment) and the observation group(n=68, treated with Chanbei mixture), with a 2-week treatment course for both groups. The daytime cough symptom score(DCSS), nighttime cough symptom score(NCSS), total cough symptom score(TCSS), IgE, EOS, TNF-α, IL-6, clinical efficacy and adverse reactions were compared between the two groups before and after treatment.

    Results

    After treatment, DCSS, NCSS, TCSS, EOS count and the levels of IgE, TNF-α and IL-6 in both groups were significantly lower than those before treatment, and the reduction amplitudes in the observation group were greater than those in the control group(all P<0.05).

    Conclusion

    Chanbei mixture can effectively relieve the symptoms of PIC, and significantly reduce serum IgE, TNF-α, IL-6 levels and peripheral blood EOS count.

  • Article
  • Xuemin WANG , Fuquan LONG , Mingxia WANG , Huan SHI , Fang SHEN , Wencheng JIANG
    doi: 10.13683/j.wph.2026.07.007
    Objective

    To verify the clinical efficacy and safety of external application of Ji Desheng snake tablets for herpes zoster with liver-gallbladder damp-heat syndrome.

    Methods

    A total of 120 patients with acute herpes zoster and liver-gallbladder damp-heat syndrome in Shanghai Skin Disease Hospital from April to December 2024 were enrolled and randomly divided into the experimental group and the control group, with 60 cases in each group. Both groups were given intravenous acyclovir and oral mecobalamin. The experimental group was additionally treated with external application of Ji Desheng snake tablets, while the control group was given a placebo instead of the tablet. The course of treatment was 1 week, with a 90-day follow-up. The quantitative scoring of symptom and sign, visual analogue scale(VAS) score, blister cessation time, crusting time, decrustation time, incidence of postherpetic neuralgia, and Dermatology Life Quality Index(DLQI) score were compared between the two groups. Adverse reactions were also recorded.

    Results

    A total of 116 patients completed the study. The total effective rate of the experimental group was higher than that of the control group(98.27% vs. 62.07%, P<0.05). The blister cessation time and crusting time in the experimental group were shorter than those in the control group(P<0.05), while there was no significant difference in decrustation time between the two groups(P>0.05). There was no significant difference in VAS score between the two groups(P>0.05). The incidence of postherpetic neuralgia in the experimental group was lower than that in the control group(10.34% vs. 25.86%, P<0.05).The DLQI score of the experimental group was lower than that of the control group(P<0.05). There was no statistically significant difference in the incidence of adverse reactions between the two groups(P>0.05).

    Conclusion

    External application of Ji Desheng snake tablets can be safely used in patients with acute-stage herpes zoster with liver-gallbladder damp-heat syndrome. It can promote skin lesion repair and reduce the incidence of postherpetic neuralgia, and is worthy of clinical promotion.

  • Article
  • Zezheng LI , Shibin HAN , Shuai HUANG
    doi: 10.13683/j.wph.2026.07.008
    Objective

    To compare the application value of semaglutide and liraglutide in patients with obese type 2 diabetes mellitus(T2DM).

    Methods

    A total of 150 obese T2DM patients admitted to Linquan county people's hospital from March 2023 to October 2024 were prospectively selected for this study. The subjects were divided into group A and group B by simple sorting randomization method, with 75 cases in each group. All patients received conventional treatment. On this basis, group A was given semaglutide, while group B was treated with liraglutide. The treatment course of both groups was 24 weeks. The improvement effects of body mass index(BMI), blood glucose, islet function and blood lipids were compared between the two groups, and the incidence of cardiovascular events and other adverse reactions was also compared.

    Results

    After treatment, the BMI of group A was lower than that of group B(P<0.05), but there was no statistically significant difference in waist-to-hip ratio between the two groups(P>0.05). There was no statistically significant difference in the hypoglycemic effect between the two groups(P>0.05). The insulin resistance of group A was lower than that of group B, while the pancreatic β-cell function was higher than that of group B, and the differences were statistically significant(P<0.05). The levels of triglyceride, total cholesterol and low-density lipoprotein cholesterol in group A were lower than those in group B, while the level of high-density lipoprotein cholesterol was higher than that in group B, and all the differences were statistically significant(P<0.05). The incidence of cardiovascular events in group A was lower than that in group B(P<0.05), and the occurrence of adverse drug reactions was similar between the two groups(P>0.05).

    Conclusion

    Compared with liraglutide, semaglutide can more significantly control body weight, improve insulin resistance and regulate blood lipids in obese T2DM patients, bring short-term cardiovascular benefits to patients.

  • Article
  • Min ZHANG , Jie ZOU , Lei CHEN
    doi: 10.13683/j.wph.2026.07.009
    Objective

    To explore the clinical effect of Tuihong Qucuo formula assisted standard Western medicine in the treatment of acne patients with blood stasis and phlegm coagulation type.

    Methods

    A total of 104 patients with acne of blood stasis and phlegm coagulation type from Ankang Traditional Chinese Medicine Hospital from February 2021 to January 2024 were selected as the study subjects. They were divided into the control group and the combined group by simple randomization method, with 52 cases in each group. The control group received standard Western medicine treatment, while the combined group received Tuihong Qucuo formula assisted standard Western medicine.The clinical efficacy, traditional Chinese medicine(TCM) syndrome scores, skin barrier, serum inflammatory factors, microRNA(miR), incidence of adverse reactions, and recurrence rate were compared between the two groups.

    Results

    The total effective rate of the combined group was higher than that of the control group(98.08% vs. 84.62%, P<0.05).After 3 courses of treatment, the TCM syndrome score, transcutaneous water loss, pH value, sebum secretion of skin, miR-5195-3p, miR-144-5p, the levels of interleukin-8, toll like receptor 2, tumor necrosis factor-α and recurrence rate in the combined group were lower than those in the control group, while the water content in the stratum corneum in the combined group was higher than that in the control group(P<0.05). There was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).

    Conclusion

    Tuihong Qucuo formula assisted standard Western medicine has a significant effect on acne of blood stasis and phlegm coagulation type. It can not only improve the clinical symptoms, repair the skin barrier, but also reduce the inflammatory reaction in the body, reduce the recurrence rate, with a favorable safety profile.

  • Article
  • Ling DU , Weiju YI , Yun TENG
    doi: 10.13683/j.wph.2026.07.010
    Objective

    To explore the postoperative effect of Buxue Yimu pill combined with estrogen in the treatment of mild to moderate intrauterine adhesions and its impact on endometrial thickness.

    Methods

    A total of 86 postoperative patients with intrauterine adhesions admitted to Yuechi county maternal and child health hospital in Guang'an city from March 2020 to October 2025 were selected as the study subjects. They were randomly divided into the observation group and the control group using a simple sequential randomization method, with 43 cases in each group. The control group was treated with estrogen, while the observation group was treated with Buxue Yimu pill combined with estrogen. After 8 weeks of treatment, the clinical efficacy, endometrial thickness, uterine volume, uterine artery pulsatility index(PI), uterine artery resistance index(RI), improvement in menstrual volume, pregnancy status, and incidence of adverse reactions were compared between the two groups.

    Results

    After treatment, the total effective rate of the observation group was higher than that of the control group(88.37% vs 69.77%, P<0.05). The endometrial thickness and uterine volume of both groups were improved compared with those before treatment, and the observation group was superior to the control group(all P<0.05). The PI and RI in both groups were decreased compared with those before treatment, and the observation group was lower than the control group(all P<0.05). The improvement of menstrual volume and pregnancy outcome in the observation group were significantly better than those in the control group(all P<0.05). There was no statistically significant difference in the incidence of adverse reactions between the two groups(P>0.05).

    Conclusion

    The combination of Buxue Yimu pill and estrogen can effectively increase the thickness of the endometrium in patients who have undergone mild to moderate uterine cavity adhesion surgery. It can effectively prevent the recurrence of adhesions after the surgery and achieve satisfactory overall outcomes.

  • Article
  • Juan LIU , Lei WANG , Lu LEI
    doi: 10.13683/j.wph.2026.07.011
    Objective

    To explore the clinical efficacy of Yanhusuo in postoperative analgesia and wound healing promotion after anorectal surgery.

    Methods

    A retrospective study was conducted on 132 patients who underwent anorectal surgery. They were divided into the Yanhusuo group(treatment with Yanhusuo decoction combined with routine dressing change) and the control group(treatment with 1∶4 000 potassium permanganate solution combined with routine dressing change), with 66 patients in each group. The overall clinical efficacy, postoperative pain assessed by the numerical rating scale(NRS), serum prostaglandin(PG)E2, β-endorphin(EP), wound healing time, time to wound edema resolution time, frequency of dressing change, and occurrence of complication were compared between the two groups.

    Results

    After the treatment, the overall clinical efficacy of the Yanhusuo group was superior to that of the control group(P<0.05). At postoperative days 3, 7 and 14, the NRS scores, PGE2 and β-EP levels, wound healing time and time to wound edema resolution, and the frequency of dressing changes in the Yanhusuo group were all significantly lower than those in the control group(P<0.05). The incidence of postoperative complications in the Yanhuxiu group was 9.09%, which showed no statistically significant difference compared with the 15.15% in the control group(P>0.05).

    Conclusion

    After anorectal surgery, the use of Yanhusuo can relieve pain and promote wound healing, and its effect is good.

  • Article
  • Huizhong CAI , Jie SHEN , Weiju JIANG
    doi: 10.13683/j.wph.2026.07.012
    Objective

    To analyse the predictive value of serum thrombospondin(TSP)-2, antithrombin(AT)-Ⅲ, and glutathione peroxidase(GPX)1 for postpartum hemorrhage(PPH), and to observe the effect of carboprost tromethamine injection on the above indicators in PPH patients.

    Methods

    A total of 285 parturients admitted to our hospital from January 2024 to May 2025 were enrolled in this study. They were divided into the PPH group(n=52) and the control group(n=233) according to their bleeding status, and the changes in serum TSP-2, AT-Ⅲ and GPX1 levels were analyzed.Multivariate unconditional logistic regression was used to analyze the risk factors for PPH, and the receiver operating characteristic(ROC) curve was adopted to evaluate the predictive performance of serum TSP-2, AT-Ⅲ and GPX1. The PPH group received adjuvant treatment with carboprost tromethamine injection, and the therapeutic effect was analyzed.

    Results

    Multivariate unconditional logistic regression showed that age, mode of delivery, use of oxytocin during labor, delivery history, the duration from labor induction to delivery, neonatal weight, serum TSP-2, AT-Ⅲ and GPX1 were all independent risk factors for PPH(P<0.05). For predicting PPH, the AUC, sensitivity and specificity of serum TSP-2 were 0.750, 79.50% and 82.20% respectively, serum AT-Ⅲ were 0.799, 72.50% and 78.30%, serum GPX1 were 0.672, 75.50% and 79.60%, and the combined detection were 0.897, 91.05% and 93.13%. After treatment, the levels of serum TSP-2, AT-Ⅲ and GPX1 in the PPH group were significantly improved(P<0.05).

    Conclusion

    The abnormal levels of serum TSP-2, AT-Ⅲ and GPX1 in PPH patients are associated with the incidence of PPH and hold potential reference value for clinical screening and identification of high-risk populations for PPH. There are multiple independent risk factors for PPH, and targeted precise interventions should be carried out around these high-risk factors in clinical practice, with focused attention on high-risk populations. The adjuvant application of carboprost tromethamine injection in the emergency management and prevention of PPH can effectively improve the maternal prognosis, which is worthy of clinical promotion.

  • Article
  • Jiayi RU , Yamin LIU , Xiaoqing ZHANG
    doi: 10.13683/j.wph.2026.07.013
    Objective

    Based on the FAERS database to mine the adverse drug events(ADE) signals of three commonly used anti-tumor drugs of paclitaxel class(paclitaxel, albumin-bound paclitaxel, docetaxel), and to explore the relationship between ADE occurrence and the drugs.

    Methods

    Extracted the ADE reports from the FAERS database from the first quarter of 2006 to the second quarter of 2025. Signal mining was performed on the reports of the three paclitaxel drugs using the reporting odds ratio(ROR) and proportional reporting ratio(PRR) methods, and the ADE signals were analyzed using standardized medical terms.

    Results

    A total of 78 855 ADE reports related to paclitaxel(the drug primarily suspected) were collected, with 779 ADE signals, 27 557 ADE reports for albumin-bound paclitaxel were received, with 399 ADE signals, and 173 944 ADE reports for docetaxel were obtained, with 574 ADE signals. The most frequent ADE associated with paclitaxel was respiratory distress, involving a total of 27 system organ classes(SOC), mainly including systemic diseases and administration site conditions, respiratory system disorders, thoracic and mediastinal diseases, gastrointestinal diseases. For albumin-bound paclitaxel, the most frequently occuring ADE was death, involving 24 SOC, primarily including systemic diseases and administration site conditions, gastrointestinal diseases, and blood and lymphatic system diseases. For docetaxel, the most frequently occurring ADE was alopecia, involving a total of 25 SoC, mainly including skin and subcutaneous tissue diseases, mental disorders, systemic diseases and administration site conditions.

    Conclusion

    Mining of the FAERS database enables an in-depth analysis of the safety warning signals of paclitaxel, albumin-bound paclitaxel and docetaxel, providing a reference for clinical safe and rational drug selection.

  • Article
  • Yu CHEN , Gang FANG , Wei LI , Jinxi DING
    doi: 10.13683/j.wph.2026.07.014
    Objective

    To evaluate the cost-effectiveness of recombinant human TNK tissue-type plasminogen activator(TNK) versus alteplase in adult patients with acute ischemic stroke from the perspective of Chinese health system.

    Methods

    Based on individual patient data from the phase Ⅲ clinical trial TRACE-2(NCT04797013) of TNK in China, a decision tree and Markov hybrid model was constructed to simulate both a 1-year short-term and a lifetime horizon. The incremental cost-effectiveness ratio(ICER) of TNK versus alteplase was calculated, and sensitivity analysis were performed to test the robustness of the results.

    Results

    Compared with alteplase, TNK provided an incremental gain of 0.016 quality-adjusted life years(QALYs) and saved 65.29 yuan over a 1-year horizon, and provided 0.118 QALYs gained and saved 2 306.68 yuan over the lifetime horizon. TNK was dominant over alteplase in both time horizons.

    Conclusion

    From the perspective of the Chinese health system, TNK is cost-effective compared with alteplase for adult patients with acute ischemic stroke in China.

  • Review
  • Jingchao LI , Jianjun CHEN , Wei JIA , Guanchun HUA , Li MI
    doi: 10.13683/j.wph.2026.07.015

    Hyperlipidemia is an important risk factor for cardiovascular and cerebrovascular diseases, and its pathogenesis involves abnormal regulation of multiple key signaling pathways. Traditional Chinese medicine has the advantages of multi-target and multi-pathway in regulating lipid metabolism and improving hyperlipidemia. By intervening in signaling pathways such as adenosine monophosphate activated protein kinase, peroxisome proliferator activated receptor, sterol regulatory element binding protein, liver X receptor, and nuclear factor-κB, it can effectively regulate the synthesis and metabolism of cholesterol and triglycerides. This article reviewed the regulatory mechanisms and experimental research progress of traditional Chinese medicine compound formulas on hyperlipidemia related signaling pathways, providing theoretical basis for clinical applications and new drug development.

  • Review
  • Lili YU , Xiaomei HE , Tongfei LI , Peng CHEN , Ping HUANG , Yingqiang LI
    doi: 10.13683/j.wph.2026.07.016

    Dihydroartemisinin(DHA), as a first-line antimalarial drug, exhibits better pharmacokinetic characteristics compared to artemisinin, including higher absorption efficiency, broader tissue distribution, and lower toxicity. As the multi-target anti-tumor mechanism of DHA has gradually become clear, it has been regarded as a repurposed anti-tumor candidate with translational potential. DHA can inhibit the proliferation, invasion and metastasis of tumor cells, and induce apoptosis and autophagy. It can also regulate the tumor microenvironment(TME), inhibit angiogenesis, interfere with the functions of cancer-associated fibroblasts, and reshape the signal transmission between immune cells, thereby weakening tumor immunosuppression. This review summarized the specific roles of DHA in the TME, and demonstrated that DHA, as a potential anti-tumor drug, held significant clinical value.

  • Review
  • Qingxiu SUN , Fenghua PU
    doi: 10.13683/j.wph.2026.07.017

    Human epidermal growth factor receptor(HER)2 positive breast cancer is a specific type of breast cancer that typically has a higher invasiveness and poorer prognosis. Targeted drugs such as trastuzumab and pertuzumab can specifically bind to HER2 receptors, inhibit the growth and spread of cancer cells, and prolong the survival of patients.traditional Chinese medicine(TCM), as a precious treasure of the nation, having accumulated rich experience in the treatment of breast cancer. It could enhance clinical treatment outcomes, reduce adverse reactions, improve patients'immune function, serve as an important complementary approach to breast cancer treatment. The combination of targeted drugs with TCM has achieved good results in the treatment of HER2 positive breast cancer. Based on the current situation of traditional Chinese medicine combined with targeted drugs in the treatment of HER2 positive breast cancer, this paper analyzed and summarized existing studies to provide a reference for comprehensive clinical treatment of breast cancer..

  • Pharmacy administration
  • Xingxing XIE , Pei WANG , Ming HU
    doi: 10.13683/j.wph.2026.07.018
News